MERIT
LIVE

Serial Number

86633739

Owner

Merit Healthcare International, Inc.

Attorney

Matthew J. Clark

First Use Date

Jun 25, 1982

Filing Date

May 18, 2015

Add to watchlist:

No watchlists yet
View on USPTO

MERIT Trademark

Serial Number: 86633739 • Registration: 5148820

MERIT is a trademark filed by Merit Healthcare International, Inc. on May 18, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Merit Healthcare International, Inc.

2611 N. San Fernando Rd.
Los Angeles, CA 90065

Entity Type: 03

Trademark Details

Filing Date

May 18, 2015

Registration Date

February 28, 2017

First Use Anywhere

June 25, 1982

First Use in Commerce

June 25, 1982

Published for Opposition

December 13, 2016

Goods & Services

[ Pharmaceuticals for the treatment of medical conditions, namely, prescription pharmaceutical products, oral pharmaceuticals, and topical pharmaceuticals for the treatment of infectious diseases, skin diseases and conditions, and internal diseases and conditions; Vaccines; ] Nutritional supplements; [ Pharmaceutical preparations, namely, general anesthetics, sedatives, anti-infectives, cardiovascular pharmaceuticals, anti-emetics, and diluents for use in reconstituting and diluting other pharmaceutical agents; ] Dietetic substances, namely, vitamins [, lipids, amino acids for medical purposes, and electrolytes; Full line of pharmaceutical preparations for intravenous administration, namely, electrolytes, saline solution for medical purposes, dextrose, heparin, lactated ringers; Anti-infective agents; Medical solutions for intermittent or continuous intravenous infusion for treatment of cardiovascular disease, prevention or treatment of infections; Critical care premixed medicines for fluid replacement; Medicated skin ointment; Medical solutions for wound irrigation; Fluids for parenteral medical use, namely, mineral, vitamin, or nutritionally enhanced water for injection for medical purposes, dextrose in water, dextrose and sodium chloride in water, sodium chloride in water, dextrose and vitamins in water, dextrose, sodium chloride, and vitamins in water, dextrose, alcohol, sodium chloride, and vitamins in water, dextrose, alcohol, and vitamins in water, sodium chloride, potassium chloride, and calcium chloride in water, dextrose, sodium chloride, potassium chloride, and calcium chloride in water, sodium r-lactate in water, sodium r-lactate, sodium chloride, potassium chloride, and calcium chloride in water, sodium r-lactate, sodium chloride, potassium chloride, calcium chloride, and dextrose in water, dextrose, alcohol, and sodium chloride in water, hydrolyzed protein in water, and sodium sulfate in water, for medical purposes; Solutions for parenteral medical use, namely, various concentrations of dextrose in water, various concentrations of dextrose and sodium chloride in water, various concentrations of sodium chloride in water, various concentrations of vitamins in water, various concentrations of dextrose with sodium chloride and vitamins in water, various concentrations of dextrose and alcohol with sodium chloride and vitamins in water, various concentrations of dextrose and alcohol with vitamins in water, sodium chloride, potassium chloride, and calcium chloride in water, various concentrations of calcium chloride in water, sodium r-lactate, sodium chloride, potassium chloride, and calcium chloride in water, sodium r-lactate in water, various concentrations of dextrose and alcohol with sodium chloride in water, various concentrations of dextrose and alcohol in water, various concentrations of magnesium sulfate in water, for medical purposes; Medicated water for the treatment of infectious diseases, skin diseases and conditions, and internal diseases and conditions; Various concentrations of sodium citrate in water, various concentrations of potassium chloride, sodium chloride, and sodium lactate in water, various concentrations of potassium chloride in water, various concentrations of invert sugar in water, various concentrations of invert sugar and sodium chloride in water, and sodium chloride, potassium chloride, and calcium chloride with dextrose in water for medical purposes; Solutions for enteral use, namely, various concentrations of hydrolyzed protein with carbohydrates and minerals in water for medical purposes; Blood anticoagulant and preservative agents, namely, heparin; Various concentrations of sodium citrate in water for medical purposes, various concentrations of dextrose, sodium citrate, and sodium chloride in water for medical purposes, and various concentrations of citric acid in water for medical purposes ]

[ Providing information relating to therapeutic properties of pharmaceuticals relating to the treatment of medical conditions to healthcare providers and patients ]

[ Sterile non-pyrogenic distilled water used as a diluent for parenteral injection solutions ]

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 28, 2026 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 13, 2024 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 13, 2024 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 13, 2024 APRE
TEAS SECTION 8 & 15 RECEIVED
Aug 28, 2023 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 28, 2022 REM1
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 2, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 2, 2019 REAP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 27, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 27, 2018 REAP
REGISTERED-PRINCIPAL REGISTER
Feb 28, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 13, 2016 NPUB
PUBLISHED FOR OPPOSITION
Dec 13, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 23, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 31, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 26, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 25, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 25, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 28, 2016 GNRN
NON-FINAL ACTION E-MAILED
Apr 28, 2016 GNRT
NON-FINAL ACTION WRITTEN
Apr 28, 2016 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 8, 2016 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 8, 2016 TCCA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 8, 2015 GNRN
NON-FINAL ACTION E-MAILED
Sep 8, 2015 GNRT
NON-FINAL ACTION WRITTEN
Sep 8, 2015 CNRT
ASSIGNED TO EXAMINER
Aug 27, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 27, 2015 NWOS